Market Tracker

10/20 5:16pm ET

Baxter International Inc (NYSE:BAX)

63.59
Delayed Data
As of Oct 20
 +0.12 / +0.19%
Today’s Change
43.13
Today|||52-Week Range
64.75
+43.41%
Year-to-Date
Dan Loeb Buys Activist Stake in Dover Corp in 3rd Quarter
Oct 20 / GuruFocus News - Paid Partner Content
Baxter International (BAX) Q3 Earnings: What's in Store?
Oct 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close63.47
Today’s open63.71
Day’s range63.40 - 63.91
Volume2,738,550
Average volume (3 months)2,371,605
Market cap$34.6B
Dividend yield1.01%
Data as of 4:01pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+410.02%
Earnings growth (this year)+21.82%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+1.96%
P/E ratio38.5
Price/Sales2.40
Price/Book4.14

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-1.44-1.03%
ZTSZoetis Inc+0.36+0.55%
INCYIncyte Corp-0.08-0.07%
VRTXVertex Pharmaceutica...+0.03+0.02%
Data as of 4:14pm ET, 10/20/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)$0.59
Annual revenue (last year)$10.2B
Annual profit (last year)$4.9B
Net profit margin48.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Joe Almeida
Vice President-
Operations
Scott Pleau
Corporate headquarters
Deerfield, Illinois

Forecasts